Navigation Links
August 2008 Mayo Clinic Women's HealthSource Highlights Avoiding Blood Pressure Increase at Menopause, Healthful Benefits of Dark Chocolate and Scheduling a Colorectal Exam
Date:8/6/2008

t issue of Mayo Clinic Women's HealthSource. Flavonoids are a naturally occurring antioxidant that also are found in teas, red wine and some fruits and vegetables.

The flavonoids in dark chocolate have been associated with a beneficial effect on the cardiovascular system. One recent study showed that 6 grams of dark chocolate a day, about one square, lowered systolic and diastolic blood pressure by 2 points each.

Dark chocolate also may lower low-density lipoprotein (LDL) cholesterol levels by about 5 points. While not a huge affect, it's sending that "bad" cholesterol in the right direction. Also, flavonoids have a beneficial effect on how the lining of the blood vessels function.

"We think a lot of bad things that happen to the cardiovascular system are because the lining of the vessels cracks and becomes inflamed, setting the stage for plaques to form and rupture," says Robert Sheeler, M.D., a family physician at Mayo Clinic.

To gain the health benefits, there's no need to eat a whole chocolate bar. After all, chocolate still contains calories and fat. Dr. Sheeler says just one square a day, about 30 calories worth, will provide the health benefits.

Generally, to gain health benefits, Dr. Sheeler recommends chocolate that contains at least 60 percent cocoa. Milk chocolate typically has 15 percent to 25 percent cocoa. Dark chocolate tends to have 50 percent to 80-plus percent cocoa. And no need to buy the priciest brands. Some high-quality dark chocolate bars are available for $2 to $4 each.

Most Important Choice -- Schedule a Colorectal Exam

More options are available for colon cancer screenings

ROCHESTER, Minn. -- For many women, scheduling a screening for a colorectal cancer isn't on the radar. Some mistakenly believe it's a man's disease.

That misperception could be deadly. Colorectal cancer is the third-leading cause of cancer deaths among women, after lung cancer and breast cancer. And, a majorit
'/>"/>

SOURCE Mayo Clinic
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors Visits
2. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
3. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
11. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2009)... , REYKJAVIK, Iceland, July 1 /PRNewswire-F... schizophrenia ever undertaken has revealed severa...ce of the human genome (SNPs) linked to,risk of t...um of scientists,led by a team from deCODE geneti... than 50,000 patients and control participants fro...
(Date:6/30/2009)... , FRAZER, Pa., June 30 /PRNewswire-FirstCall/ ...d that it has submitted a supplemental New Drug Ap...tration (FDA) requesting approval of NUVIGIL(R) (a...mproved wakefulness in patients with excessive sle... from eastbound travel. Jet lag disorder is an ac...
(Date:6/29/2009)... , Study in major abdominal surgery patients ac...OOD CITY, Calif., June 29 AcelRx P...lts from the second Phase 2 clinical study evaluat...il NanoTabs(TM) for the management of acute post-o...ia during hospitalization. Compared to placebo, pa...
(Date:6/28/2009)... , CHIPPENHAM, England and TOKYO, June 29 /...estones for Both Companies , Sosei Group Co...ectura,Group plc ("Vectura"; LSE: VEC) announce t...Novartis, with NVA237, a once-daily, long-acting m...chronic obstructive pulmonary disease,(COPD). NVA...
Breaking Medicine Technology:deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 2deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 3deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 4deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 5Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 2Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 3Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 4AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4Study finds rescue course of antenatal steroids improves outcome in premature babies 6843 1Study finds rescue course of antenatal steroids improves outcome in premature babies 6843 2Alliance of Experts Created to Help Raise Awareness of Best Practices in Diabetes Treatment 35172 1Alliance of Experts Created to Help Raise Awareness of Best Practices in Diabetes Treatment 35172 2Alliance of Experts Created to Help Raise Awareness of Best Practices in Diabetes Treatment 35172 3Health Integrated Achieves NCQA Full Accreditation for Its Synergy Targeted Population Management 28TM 29 Program 35170 1Health Integrated Achieves NCQA Full Accreditation for Its Synergy Targeted Population Management 28TM 29 Program 35170 2Today Show and American Legacy Foundation 28R 29 Team Up to Help Smokers Call it Quits 35169 1Today Show and American Legacy Foundation 28R 29 Team Up to Help Smokers Call it Quits 35169 2Today Show and American Legacy Foundation 28R 29 Team Up to Help Smokers Call it Quits 35169 3Today Show and American Legacy Foundation 28R 29 Team Up to Help Smokers Call it Quits 35169 4Today Show and American Legacy Foundation 28R 29 Team Up to Help Smokers Call it Quits 35169 5
... Calif., April 18, 2007,/PRNewswire-FirstCall/ -- ... data from a preclinical study in which BiTE(R) mo...ere shown to prevent,subcutaneous tumor growth and...er for tumor progression, CEA is frequently,expres...hese data,presented yesterday in a poster session...
...r 19, 2007 - Antares Pharma, Inc.,(AMEX: AIS) anno...ite application study demonstrating that ANTUROL(R...sorbed on a bioequivalent,basis after a single-dos...ns., The study was an open-label, comparative thre...study. The trial enrolled 25,healthy subjects (80%...
Other Medicine Technology:Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA 2Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA 3Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA 4Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA 5Antares Pharma Announces Positive Results from Application Site,Study for Anturol 2Antares Pharma Announces Positive Results from Application Site,Study for Anturol 3
(Date:7/2/2009)...re,s Bioprocessing Technology Institute (BTI) have...poptosis inhibitory molecule" (FAIM), protects bot...mmed cell death. , Their research is published ...tion . , The scientists, Jianxin Huo, Ph.D., and...ess may possibly be manipulated for clinical appli...
(Date:7/2/2009)...uly 2 Acetaminophen is ...rescription medicines to help relieve pain and red...a brand name, Tylenol and prescription brand names...tee for the FDA met on June 30, 2009 to address li...en. The committee voted 20-17 to urge the FDA to ...
(Date:7/2/2009)... 63 businesses honored in Washington, D.C. , ,...-- Texas Health Resources has received the Best...National Business Group on Health. , , (Logo: ...1773LOGO ) , , The award recognizes the nati...that promote a healthy workplace and for helping e...
(Date:7/2/2009)...roblems faced by youngsters with the disease , ...dren with type 1 diabetes are more likely to be ov...g their risk of serious health complications, rese...y that explored the weight problems faced by U.S. ...m of the disease that usually shows up in childhoo...
Breaking Medicine News(10 mins):Health News:Gene's novel role may provide key to treating liver and neurodegenerative diseases 2Health News:Viles & Beckman, LLC: Stop Your Headache NOT Your Liver 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 3Health News:Kids With Type 1 Diabetes Often Overweight 2
...assage as a treatment for chronic neck pain, but i...n used over long periods.That's the conclusion of ...ness of the complementary medicine technique, whic...ial sites in the nervous system.// The study compa...
...rs many cancer survivors report a good quality of ...ruggle. But generally Doctors and the general publ... in your quality of life. Researchers at the King ...arried out a survey on a group of women who had su...
...urnal of the American Medical Association. Coronar...cystine levels with a diet supplement of folic aci...Tice from the University of California at San Fran... Heart Disease Policy Model to assess the cost eff...
...ical Industries entered the antismoking segment wi... The medication in Smoquit has been used for over ...nt dose. The Rs. 13.50-per tablet priced Smoquit, ... treatment of smoking problem, is a prescription d...
Other Medicine News:
Derived from an extensive study into increasing the range of motion in hip replacement, the cemented SHP acetabular cup is a unique design and is manufactured from ArCom polyethylene.
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects.
Duraloc 400 series cup.
The Trident PSL Acetabular Shells are designed to maximize fixation in the peripheral lunate region of the acetabulum.
Medicine Products: